Literature DB >> 2010737

Colloids versus crystalloids in fluid resuscitation: an analysis of randomized controlled trials.

R S Bisonni1, D R Holtgrave, F Lawler, D S Marley.   

Abstract

BACKGROUND: Controversy about fluid therapy in resuscitation has existed since the 1960s. The difficulty could be that fluid behavior at the lung capillary membrane level may vary depending on the patient's particular pathology.
METHODS: Mortality rates taken from randomized controlled trials were analyzed to compare colloidal and crystalloidal fluid for resuscitation efforts. We controlled for the underlying pathological process by categorizing subjects into three groups: (1) surgical stress, (2) hypovolemia, and (3) severe pulmonary failure. A cost-effectiveness analysis also was performed.
RESULTS: No statistically significant differences in mortality rates were found. The cost of each life saved using crystalloids is $45.13, and the cost of each life saved using colloidal solutions is $1493.60.
CONCLUSIONS: Because there is no significant mortality-rate advantage to using colloids, and because the cost-effectiveness ratio for crystalloids is much lower than for colloids, it is concluded that crystalloids should always be used in resuscitation efforts.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2010737

Source DB:  PubMed          Journal:  J Fam Pract        ISSN: 0094-3509            Impact factor:   0.493


  7 in total

1.  Fluid resuscitation in neonatal and pediatric hypovolemic shock: a Dutch Pediatric Society evidence-based clinical practice guideline.

Authors:  Nicole Boluyt; Casper W Bollen; Albert P Bos; Joke H Kok; Martin Offringa
Journal:  Intensive Care Med       Date:  2006-05-24       Impact factor: 17.440

2.  The effects of commonly used resuscitation fluids on whole blood coagulation.

Authors:  T J Coats; E Brazil; M Heron
Journal:  Emerg Med J       Date:  2006-07       Impact factor: 2.740

3.  Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: a systematic review of randomised trials.

Authors:  G Schierhout; I Roberts
Journal:  BMJ       Date:  1998-03-28

4.  Consensus statement of the ESICM task force on colloid volume therapy in critically ill patients.

Authors:  Konrad Reinhart; Anders Perner; Charles L Sprung; Roman Jaeschke; Frederique Schortgen; A B Johan Groeneveld; Richard Beale; Christiane S Hartog
Journal:  Intensive Care Med       Date:  2012-02-10       Impact factor: 17.440

5.  Management of bleeding following major trauma: an updated European guideline.

Authors:  Rolf Rossaint; Bertil Bouillon; Vladimir Cerny; Timothy J Coats; Jacques Duranteau; Enrique Fernández-Mondéjar; Beverley J Hunt; Radko Komadina; Giuseppe Nardi; Edmund Neugebauer; Yves Ozier; Louis Riddez; Arthur Schultz; Philip F Stahel; Jean-Louis Vincent; Donat R Spahn
Journal:  Crit Care       Date:  2010-04-06       Impact factor: 9.097

6.  Management of bleeding following major trauma: a European guideline.

Authors:  Donat R Spahn; Vladimir Cerny; Timothy J Coats; Jacques Duranteau; Enrique Fernández-Mondéjar; Giovanni Gordini; Philip F Stahel; Beverley J Hunt; Radko Komadina; Edmund Neugebauer; Yves Ozier; Louis Riddez; Arthur Schultz; Jean-Louis Vincent; Rolf Rossaint
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

7.  Severe sepsis: variation in resource and therapeutic modality use among academic centers.

Authors:  D Tony Yu; Edgar Black; Kenneth E Sands; J Sanford Schwartz; Patricia L Hibberd; Paul S Graman; Paul N Lanken; Katherine L Kahn; David R Snydman; Jeffrey Parsonnet; Richard Moore; Richard Platt; David W Bates
Journal:  Crit Care       Date:  2003-03-17       Impact factor: 9.097

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.